Cecilie Bendigtsen Schirmer

Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer

Gro Wiedswang, Elin Borgen, Cecilie Bendigtsen Schirmer et al. · International Journal of Cancer · 2005 · 129 citations

Medicine, Oncology, Pathology +15

Clinical Outcome With Correlation to Disseminated Tumor Cell (DTC) Status After DTC-Guided Secondary Adjuvant Treatment With Docetaxel in Early Breast Cancer

Bjørn Naume, Marit Synnestvedt, Ragnhild Sørum Falk et al. · Journal of Clinical Oncology · 2014 · 89 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma

Harald Hugenschmidt, Knut Jørgen Labori, Cathrine Brunborg et al. · Annals of Surgery · 2018 · 57 citations

Medicine, Oncology, Surgery +16

Preoperative CTC-Detection by CellSearch® Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer

Harald Hugenschmidt, Knut Jørgen Labori, Elin Borgen et al. · Cancers · 2021 · 41 citations · Full text

Medicine, Oncology, Pathology +17

Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study

Marit Synnestvedt, Elin Borgen, Erik Wist et al. · BMC Cancer · 2012 · 21 citations · Full text

Medicine, Oncology, Pharmacology +14